Dec'04 | Dec'05 | Dec'06 | Dec'07 | Dec'08 | Dec'09 | Dec'10 | Dec'11 | Dec'12 | Dec'13 | Dec'14 | Dec'15 | Dec'16 | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow | $13.7B | $12.6B | $15.5B | $11.5B | $16.5B | $15.4B | $9,941.0M | $18.6B | $15.7B | $16.3B | $15.3B | $13.0B | $13.9B | $14.3B | $13.6B | $9,994.0M | $11.6B | $29.9B | $26.0B | $4,793.0M |
Discover the top 20 best undervalued stocks to buy for Jan 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued large-cap growth stocks to buy for Jan 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Jan 2025.
As of today, Pfizer Inc.'s last 12-month Free Cash Flow is $8,227.0M, based on the financial report for Sep 29, 2024 (Q3 2024).
Over the last year, Pfizer Inc.'s Free Cash Flow growth was 0.6%. The average annual Free Cash Flow growth rates for Pfizer Inc. have been (14.1%) over the past three years, (5.5%) over the past five years.
Over the last year, Pfizer Inc.'s Free Cash Flow growth was 0.6%, which is higher than industry growth of (0.2%). It indicates that Pfizer Inc.'s Free Cash Flow growth is Good.